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Diabetic foot ulcers are among the most important complications of diabetes mel-
litus. In nearly 90% of persons who suffer limb loss from diabetes, ulcers precede 
amputation, and better and faster healing has been shown to reduce the frequency 
of amputations (Boulton et al., 2004). Ulcers are also associated with high mortal-
ity, and patients who have diabetes and foot ulcers have a 50% greater risk of dying 
than diabetic patients without a history of foot ulcers (Iversen et al., 2009). Poor 
healing is often observed in these patients. Therefore, a better understanding of 
which patients are likely to not heal with standard care and the reasons that these 
patients do not heal will help identify targets for intervention and indicate which 
patients may need advanced wound care modalities, such as engineered skin or 
hyperbaric oxygen.
Baseline wound characteristics such as wound size, depth, stage, and duration, as well as 4-week healing rates, 
have been found to be predictive of the likelihood of complete healing (Margolis et al., 2002). Despite the fact that 
in vitro studies and animal models suggest that glycemia impairs healing, previous studies have not found hemo-
globin A1c (HbA1c) levels to be correlated with healing; however, the study designs may have influenced these 
results. Using a novel study design, Christman and colleagues (2011, this issue) utilized electronic medical records 
from an active wound center to assess predictors of healing rates retrospectively. Delineation of wounded patients 
with diabetes into a “classic” neuropathic foot ulcer group and a complicated-wound group and multivariate anal-
ysis revealed that elevated HbA1c levels were associated with slower healing in patients with classic neuropathic 
diabetic foot ulcers and patients with peripheral vascular disease.
Understanding at-risk populations has advantages in many areas, including focusing efforts and health-care dol-
lars, improving treatment compliance, defining patients who need more advanced therapies, and identifying new 
therapeutic targets. Through the following questions, we examine this paper in greater detail. For brief answers, 
please refer to the supplementary information online <http://www.nature.com/jid/journal/v131/n10/suppinfo/
jid2011269s1.html>.
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QUESTIONS
1. Why are diabetic foot ulcers important?
2. How can one predict whether a diabetic foot ulcer will heal?
3. How did these researchers carry out their study?
4. What were the results and conclusions?
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